Finance

Beta
Lists
SPRB:NASDAQ
Spruce Biosciences, Inc
$51.89
+6.05%
(+2.96) 1D
$51.70
-0.37% (-0.19)
After hours
Closed: Jun 12, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SPRB...
Open
$49.18
High
$53.25
Low
$49.02
Mkt. cap
142.80M
Avg. vol.
46.02K
Volume
80.93K
52-wk high
$240.00
52-wk low
$7.26
EPS
-$38.31
Beta
3.12
Shares outstanding
2.75M
No. of employees
14
Open
$49.18
High
$53.25
Low
$49.02
Mkt. cap
142.80M
Avg. vol.
46.02K
Volume
80.93K
52-wk high
$240.00
52-wk low
$7.26
EPS
-$38.31
Beta
3.12
Shares outstanding
2.75M
No. of employees
14
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to SPRB in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SPRB in the last 3 months.
Highest
Current $51.89
$230.00 (+343.25%)
Average
$154.17 (+197.11%)
Lowest
$120.00 (+131.26%)
News stories
From sources across the web
About Spruce Biosciences, Inc
CEO-
Employees14
Founded2014
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitesprucebio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-430.00K
5.01M
-1.80M
7.58M
Cost of revenue
-430.00K
5.01M
-1.80M
7.58M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.12M
3.22M
5.00M
4.41M
Operating expense
3.12M
3.22M
5.00M
4.41M
Total operating expenses
2.69M
8.23M
3.20M
11.99M
Operating income
-2.69M
-8.23M
-3.20M
-11.99M
Other non operating income
-
-
-3.50M
-91.00K
EBT including unusual items
-2.07M
-8.21M
-14.65M
-12.27M
EBT excluding unusual items
-2.07M
-8.21M
-6.75M
-12.27M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.07M
-8.21M
-14.65M
-12.27M
Net profit margin
-
-
-
-
Earnings per share
-
-14.58
-9.58
-8.94
Interest and investment income
654.00K
36.00K
-
486.00K
Interest expense
-29.00K
-19.00K
-46.00K
-674.00K
Net interest expenses
625.00K
17.00K
-46.00K
-188.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.68M
-8.23M
-3.20M
-11.74M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer